Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. [electronic resource]
- American journal of respiratory and critical care medicine Mar 2001
- 918-23 p. digital